Respirology

A2B (clonidine vs. propofol)

Study

A2B (dexmedetomidine vs. propofol)

Study

Acetylcysteine

Drug

ACORN

Study

ACTIV-3-TICO

Study

ACTIV-4A (P2Y12 inhibitor plus heparin)

Study

ACTIV-4a (SGLT2 inhibitors)

Study

ACTIV-4C

Study

ACTIV-6 (fluvoxamine)

Study

ACTIV-6 (ivermectin)

Study

ACTIV-6 (montelukast)

Study

ACTT-1

Study

ACTT-4

Study

ACURASYS

Study

Acute bronchitis

Disease

Acute bronchitis — Diagnosis and management

Pathway

Acute cough

Finding

Acute lung syndrome

Finding

Acute respiratory distress syndrome

Disease

Acute respiratory distress syndrome — Management

Pathway

ADAURA

Study

ADRIATIC

Study

ADVOCATE

Study

AECOPD

Study

AEGEAN

Study

AIRFLO

Study

Albuterol

Drug

ALEX

Study

Allergic bronchopulmonary aspergillosis

Disease

ALMS

Study

Alpha-1 antitrypsin deficiency

Disease

Alveolar hemorrhage

Finding

Amantadine

Drug

AMAZES

Study

AMIKINHAL

Study

Amoxicillin

Drug

Amoxicillin / clavulanate

Drug

Amoxicillin / clavulanate XR

Drug

AMPLIFY (apixaban)

Study

AMPLIFY-EXT (apixaban 2.5 mg)

Study

AMPLIFY-EXT (apixaban 5 mg)

Study

Angiotensin converting enzyme, increased

Finding

APEX

Study

APW-RSV-II

Study

ARBs CORONA II

Study

ARDSNet

Study

AReSVi-006

Study

ART

Study

ASCEND (pirfenidone)

Study

ASPEN (brensocatib 10 mg)

Study

ASPEN (brensocatib 25 mg)

Study

ASPIRE

Study

Asthma

Disease

Atezolizumab

Drug

Atezolizumab / hyaluronidase

Drug

ATTKPATRASCOVID19

Study

ATTRACT

Study

AUSTRI

Study

AVERT

Study

Axatilimab

Drug

Azithromycin

Drug

Aztreonam

Drug